XML 13 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 235,137 $ 4 $ 428,623 $ (1,956) $ (191,534)
Beginning balance, shares at Dec. 31, 2022   37,877,387      
Issuance of common stock upon exercise of common stock options 99   99    
Issuance of common stock upon exercise of common stock options, shares   73,213      
Stock-based compensation 2,782   2,782    
Unrealized gain on available-for-sale securities 927     927  
Net loss (27,820)       (27,820)
Ending balance at Mar. 31, 2023 211,125 $ 4 431,504 (1,029) (219,354)
Ending balance, shares at Mar. 31, 2023   37,950,600      
Beginning balance at Dec. 31, 2023 130,188 $ 4 439,739 (349) (309,206)
Beginning balance, shares at Dec. 31, 2023   38,172,603      
Issuance of common stock upon vesting of restricted stock units, shares   154,049      
Stock-based compensation 2,679   2,679    
Unrealized gain on available-for-sale securities 212     212  
Net loss (26,337)       (26,337)
Ending balance at Mar. 31, 2024 $ 106,742 $ 4 $ 442,418 $ (137) $ (335,543)
Ending balance, shares at Mar. 31, 2024   38,326,652